Systemic adjuvant chemotherapy for soft tissue sarcomas;Place de la chimiotherapie adjuvante dans le traitement des sarcomes des tissus mous de l'adulte

Bulletin du Cancer

Volumn 84, Issue 6, 1997, Pages 653-663

  Debled, Marc ^a   Ravaud, Alain ^a   Stöckle, Eberhard ^a   Bui, Nguyen Binh ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

Adjuvant treatment; Chemotherapy; Soft tissue sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; META ANALYSIS; METASTASIS; PATIENT COMPLIANCE; PATIENT SELECTION; PROGNOSIS; RISK BENEFIT ANALYSIS; SIDE EFFECT; SOFT TISSUE SARCOMA; SURVIVAL; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; CHILD; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SARCOMA; SOFT TISSUE TUMOR; STATISTICAL ANALYSIS; TUMOR RECURRENCE;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0031156108     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Coindre JM, Terrier P, Bonichon F, Collin F, Le Doussal V, Mandard AM, et al. Adults soft tissue sarcoma (STS) : evolution and prognostic variables following local control. A multicentric study. Proc Am Assoc Med Oncol 1994 ; 13 : A1657.
2. Bramwell V, Rouëssé JG, Steward W, Santoro A, Schraffordt Koops H, Buesa J, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival : a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994 ; 12 : 1137-49.
3. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities. Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982 ; 196 : 305-14.
4. Geer RJ, Woodruff J, Casper ES, Brennan MF. Management of small soft-tissue sarcoma of the extremity in adults [see comments]. Arch Surg 1992 ; 127 : 1285-9.
5. Rydholm A, Gustafson P, Rooser B, Willen H, Akerman M, Herrlin K, et al. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991 ; 9 : 1757-65.
6. Fédération nationale des centres de lutte contre le cancer. Standard, options et recommandations ; sarcomes des tissus mous et ostéosarcomes. Paris : Arnette Blackwell, 1995 ; vol. 1.
7. Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993 ; 11 : 1269-75.
8. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas : a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995 ; 13 : 1537-45.
9. Eilber FR, Giuliano AE, Huth JF, Morton DL. A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma. Am J Clin Oncol 1988 ; 11 : 39-45.
10. Glenn J, Kinsella T, Glatstein E, Tepper J, Baker A, Sugarbaker P, et al. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer 1985 ; 55 : 1206-14.
11. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma : a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996 ; 14 : 869-77.
12. Guillou L, Coindre JM, Bonichon F, Bui NB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997 ; 15 : 350-62.
13. Edmonson JH. Systemic chemotherapy following complete excision of nonosseous sarcomas : Mayo Clinic experience. Cancer Treat Symp 1985 ; 3 : 89-97.
14. Edmonson JH, Fleming TR, Ivins JC, Burgert EO Jr, Soule EH, O'Connell MJ, et al. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol 1984 ; 2 : 1390-6.
15. Antman K, Ryan L, Borden E, Wood WC, Lerner HL, Corson JM, et al. Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma : 10 year results and review of the literature. In : Salmon SE, ed. Adjuvant therapy of cancer VI. Philadelphia : WB Saunders Company, 1990 ; 529-44.
16. Benjamin RS, Terjanian TO, Fenoglio CJ, Barkley HT, Evans HL, Murphy WK, et al. The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft-tissue sarcomas of the extremities. In : Salmon SE, ed. Adjuvant therapy of cancer V. Orlando : Grune & Stratton, 1987 ; 735-44.
17. Chang AE, Kinsella T, Glatstein E, Baker AR, Sindelar WF, Lotze MT, et al. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol 1988 ; 6 : 1491-500.
18. Alvegard TA, Sigurdsson H, Mouridsen H, Solheim O, Unsgaard B, Ringborg U, et al. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma : a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989 ; 7 : 1504-13.
19. Gherlinzoni F, Bacci G, Picci P, Capanna R, Calderoni P, Lorenzi EG, et al. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities : preliminary observations. J Clin Oncol 1986 ; 4 : 552-8.
20. Ravaud A, Bui NB, Coindre JM, Kantor G, Stöckle E, Lagarde P, et al. Adjuvant chemotherapy with CYVADIC in high-risk soft tissue sarcoma : a randomized prospective trial. In : Salmon SE, ed. Adjuvant therapy of cancer VI. Philadelphia : WB Saunders Company, 1990 ; 556-66.
21. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas : a Gynecologic Oncology Group Study. J Clin Oncol 1985 ; 3 : 1240-5.
22. Antman K, Suit H, Amato D, Corson J, Wood W, Proppe K, Campanacci D. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas : lack of apparent difference between treatment groups. J Clin Oncol 1984 ; 2 : 601-8.
23. Gherlinzoni F, Picci P, Bacci G, De Cazzola A, Zmerly H, et al. Late results of a randomized trial for the treatment of soft tissue sarcomas (STS) of the extremities in adult patients. Proc Am Soc Clin Oncol 1993 ; 12 : A1633.
24. Picci P, Bacci G, Gherlinzoni F, et al. Results of a randomized trial for the treatment of localized soft tissue tumors (STS) of the extremities in adult patients. In : Ryan JR, Baker LO, eds. Recent concepts in sarcoma treatment. Dordrecht, Netherlands : Kluwer Academic, 1988 ; 144-8.
25. Rosenberg SA, Chang AE, Glatstein E. Adjuvant chemotherapy for treatment of extremity soft tissue sarcomas : review of National Cancer Institute experience. Cancer Treat Symp 1985 ; 3 : 83-8.
26. Glenn J, Sindelar WF, Kinsella T, Glatstein E, Tepper J, Costa J, et al. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery 1985 ; 97 : 316-25.
27. Zalupski MM, Ryan JR, Hussein ME, Baker LH. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In : Salmon SE, ed. Adjuvant therapy of cancer VII. Philadelphia : WB Saunders company, 1993 ; 385-92.
28. Jones GW, Ghouinard E, Patel M. Adjuvant adriamycin (doxorubicin) in adult patients with soft-tissue sarcomas : a systemic overview and quantitative meta-analysis. Clin Invest Med 1991 ; 14 : A772.
29. Piver MS, Lele SB, Marchetti DL, Emrich LJ. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. J Surg Oncol 1988 ; 38 : 233-9.
30. Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MKB. Adjuvant chemotherapy for soft-tissue sarcoma : review and metaanalysis of the published results of randomized clinical trials. Br J Cancer 1995 ; 72 : 469-75.
31. Tierney JF. A meta-analysis using individual patient data from randomized clinical trials (RCTS) of adjuvant chemotherapy for soft tissue sarcomas (STS). Proc Am Soc Clin Oncol 1996 ; 15 : A2024.
32. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979 ; 63 : 1727-33.
33. Goldie JH, Coldman AJ. Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treaf Rep 1983 ; 67 : 923-31.
34. Ravaud A, Bui NB, Coindre JM, Lagarde P, Tramond P, Bonichon F, et al. Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials. Br J Cancer 1992 ; 66 : 961-9.
35. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984 ; 53 : 530-41.
36. Myrhe-Jensen O, Kaae S, Madsen EH, Sneppen O. Histopathological grading in soft tissue tumors. Relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scand (A) 1983 ; 91 : 145-50.
37. Trojani M, Contesso G, Coindre JM, Rouëssé JG, Bui NB, De Mascarel A, et al. Soft-tissue sarcomas of adults ; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984 ; 33 : 37-42.
38. Weiss SW. Histological typing of soft tissue tumours. World Health Organization, 1994.
39. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranieri E, et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 1989 ; 63 : 1437-51.
40. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity : a study of 423 adults. J Clin Oncol 1992 ; 10 : 1317-29.
41. Baker LH. Adjuvant therapy for soft tissue sarcomas. In : Ryan JR, Baker LO, eds. Recent concepts in sarcoma treatment. Dordrecht : Kluwer Academic Publishers, 1988 ; 130-5.
42. Lerner HJ, Amato DA, Savlov ED, DeWys WD, Mittleman A, Urtasun RC, et al. Eastern Cooperative Oncology Group : a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol 1987 ; 5 : 613-7.